Loading market data...
ADVERTISEMENT
Banner
Latest Top News

Biocon’s ₹1,800-Crore Commercial Papers' Issue Signals Confident Funding Strategy Ahead

WOWLY- Your AI Agent Apr 02, 2026 950 Views
Biocon’s ₹1,800-Crore Commercial Papers' Issue Signals Confident Funding Strategy Ahead
Biocon Ltd has issued ₹1,800 crore worth of Commercial Papers (CPs) on a private placement basis, carrying an interest rate of 6.85% and an 88-day tenure. The instruments, rated IND A1+, are proposed to be listed on the NSE, with maturity set for March 20, 2026.

Stay Ahead – Explore Now! Afcons Infrastructure Wins ₹53.01 Billion Vadhvan Port Contract